FILE:BSX/BSX-8K-20060303154727.txt.gz
EVENTS:	Other Events
TEXT:
ITEM: Other Events
 
UNITED STATES
 
 
Check the appropriate box below if the Form 8K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
   
 
Soliciting material pursuant to Rule 14a12 under the Exchange Act (17 CFR 240.14a-12)
o
   
 
Pre-commencement communications pursuant to Rule 14d2(b) under the Exchange Act (17 CFR 240.14d2(b))
o
   
 
Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e4(c))
o
   
 
 
 
Item 8.01.  Other Events
 
in the second quarter of 2006 and to launch commercially in the U.S. in 2007."
Language was inadvertently left out of the last sentence in the paragraph entitled "Endoscopic Video Imaging" on page 10 of Boston Scientific's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 1, 2006.  The sentence should read as follows: "We expect to conduct first-in-man trials of the Endovations System
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
March 3, 2006
Dated:
   


